An antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a $1.7 billion deal last year has been given breakthrough status by the FDA. The coveted designation for GSK5764227 ...
Japan's Taiho Pharma has reached a deal to buy Switzerland's Araris Biotech, around 18 months after they started collaborating on the development of antibody-drug conjugates (ADCs) for cancer. Taiho ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results